This suggests that the cytosolic sequestration of PRMT1 can only partially explain the early onset pathology of ALS-FUS transgenic mice and the ALS-FUS induced neurotoxicity is multilayered. The gene discussed is FUS; the disease is amyotrophic lateral sclerosis.